2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide
C22H21F5N2O3 — CID 139208344
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide
2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide (PubChem CID 139208344) has the molecular formula C22H21F5N2O3 and a molecular weight of 456.41 g/mol. Its IUPAC name is 2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide.
Molecular Properties
| Compound Name | 2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide |
|---|---|
| PubChem CID | 139208344 |
| Molecular Formula | C22H21F5N2O3 |
| Molecular Weight | 456.41 g/mol |
| Exact Mass | 456.15 |
| IUPAC Name | 2-[4-(5-ethoxy-6-oxopiperidin-3-yl)-2-fluorophenyl]-N-[2-fluoro-5-(trifluoromethyl)phenyl]acetamide |
| SMILES | CCOC1CC(c2ccc(CC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)CNC1=O |
| InChI | InChI=1S/C22H21F5N2O3/c1-2-32-19-8-14(11-28-21(19)31)12-3-4-13(17(24)7-12)9-20(30)29-18-10-15(22(25,26)27)5-6-16(18)23/h3-7,10,14,19H,2,8-9,11H2,1H3,(H,28,31)(H,29,30) |
| InChIKey | LUEMZIPQWKOMIQ-UHFFFAOYSA-N |
| XLogP | 4.17 |
| TPSA | 67.43 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.41 |
| LogP ≤ 5 | 4.17 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139208344 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.